PER percheron therapeutics limited

Ann: Clinical Trial Update, page-6

  1. 18,515 Posts.
    lightbulb Created with Sketch. 5269
    Great update, good to have a specific date for the market to get excited about.

    Also re the other announcement, I do hope punters here have done a sufficiently basic analysis of this company prior to making an investment to understand how a double blinded trial works? The company is blinded to the trial results until the data is analysed by the contract organisation, and so when they find out is when we find out. All we can go off of is the impressive results from prior trials (albeit small sample size) and feedback from all participants (can’t distinguish between control and non control group), such as requests by participants recently for post trial access due to noticeable efficacy (again though, we are double blinded so this could still be a placebo effect)…
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.9¢
Change
0.000(0.00%)
Mkt cap ! $9.786M
Open High Low Value Volume
0.9¢ 0.9¢ 0.8¢ $7.502K 844.6K

Buyers (Bids)

No. Vol. Price($)
1 112383 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 8618378 10
View Market Depth
Last trade - 15.39pm 30/07/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.